Skip to main content

Table 1 Relationship between the CircPIP5K1A level and clinical characteristics in tissue samples from glioma patients

From: CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p

Characteristics Patients Expression of CircPIP5K1A P-value
Low-CircPIP5K1A High-CircPIP5K1A
Total 45 20 25  
Age (years)
 <45 20 8 12 0.592
 ≥45 25 12 13
Gender
 Male 24 11 13 0.841
 Female 21 9 12
IDH1 mutation
 No mutation 24 10 14 0.8241
 Mutation 19 9 11
MGMT promoter methylation
 Unmethylation 26 13 12 0.5549
 Methylation 23 10 13
Tumor stage (WHO)
 I-II 27 11 16 0.014*
 III-IV 18 4 14
Ki-67 rate level
 Low 19 13 6 0.0057*
 High 26 7 19
Tumor volume
 <5 cm 28 15 11 0.036*
 ≥5 cm 17 5 14
  1. *P<0.05 was considered to be statically significant